Virtus Fund Advisers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$70K Hold
313
﹤0.01% 536
2017
Q3
$59K Sell
313
-675
-68% -$128K ﹤0.01% 429
2017
Q2
$189K Hold
988
﹤0.01% 401
2017
Q1
$163K Hold
988
﹤0.01% 411
2016
Q4
$142K Hold
988
﹤0.01% 409
2016
Q3
$124K Hold
988
﹤0.01% 416
2016
Q2
$130K Hold
988
﹤0.01% 407
2016
Q1
$137K Hold
988
﹤0.01% 414
2015
Q4
$138K Hold
988
﹤0.01% 399
2015
Q3
$138K Hold
988
﹤0.01% 386
2015
Q2
$162K Hold
988
﹤0.01% 398
2015
Q1
$153K Sell
988
-580,367
-100% -$82.6M ﹤0.01% 430
2014
Q4
$73.1M Sell
581,355
-110,300
-16% -$13.6M 0.54% 68
2014
Q3
$82.7M Sell
691,655
-596,868
-46% -$68.5M 0.63% 50
2014
Q2
$139M Buy
+1,288,523
New +$133M 0.97% 8

Other funds holding ELV

Virtus Fund Advisers's ELV Position: Q4 2017 in Review

Virtus Fund Advisers held its Elevance Health (ELV) position steady in Q4 2017 at 313 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #536.

Virtus Fund Advisers first reported a position in ELV in Q2 2014 and has held it in 15 quarters since. The position peaked at $139M in Q2 2014. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

  • Virtus Fund Advisers held 313 shares of Elevance Health worth $70K as of Q4 2017.
  • Virtus Fund Advisers left its Elevance Health share count unchanged in Q4 2017.
  • Elevance Health made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #536 holding.
  • Virtus Fund Advisers first reported a position in Elevance Health in Q2 2014 and has held it in 15 quarters since.
  • Virtus Fund Advisers's Elevance Health position peaked at $139M in Q2 2014.
  • 909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.